2-(n-myristoylamino)-1-phenyl-1-propanol and Cancer of Lung

2-(n-myristoylamino)-1-phenyl-1-propanol has been researched along with Cancer of Lung in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cebrian, A; de la Cueva, A; Gomez del Pulgar, T; Lacal, JC; Machado-Pinilla, R; Perona, R; Ramírez de Molina, A; Rodriguez-Fanjul, V	1

Other Studies

1 other study(ies) available for 2-(n-myristoylamino)-1-phenyl-1-propanol and Cancer of Lung

Article	Year
Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition. Current cancer drug targets, 2012, Volume: 12, Issue:6 Topics: Acid Ceramidase; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Butanes; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Choline Kinase; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Humans; Inhibitory Concentration 50; Lung Neoplasms; Molecular Targeted Therapy; Myristates; Oleic Acids; Propanolamines; Pyridinium Compounds; Tumor Cells, Cultured; Up-Regulation	2012

Article

Year

Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition.

Current cancer drug targets, 2012, Volume: 12, Issue:6

Topics: Acid Ceramidase; Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Butanes; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Choline Kinase; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Endocannabinoids; Enzyme Inhibitors; Ethanolamines; Humans; Inhibitory Concentration 50; Lung Neoplasms; Molecular Targeted Therapy; Myristates; Oleic Acids; Propanolamines; Pyridinium Compounds; Tumor Cells, Cultured; Up-Regulation

2012